DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




CT Homepage

Hitachi unveils new CT scanner, Scenaria View 128, at RSNA Provides better workflow with SynergyDrive and large, 80 cm aperture

Spectrum Dynamics files lawsuit against GE Alleges theft of intellectual property regarding VERITON-CT

MaxQ AI rolling out machine learning application for intercranial hemorrhage Part of a 'three-pronged' platform to improve stroke treatment

University of Utah Health among first to leverage Philips Illumeo PACS with adaptive intelligence On display at RSNA

Siemens unveils syngo Virtual Cockpit software for CT, MR and PET at RSNA Offers remote expert technicians when needed

Glassbeam partners with EQ2 and RENOVO Extending reach to CMMS users; increasing uptime of ultrasound

FDA clears Icometrix's CT assessment tool for traumatic brain injuries Toward standardized interpretation of acute non-contrast scans

Five hot topics when managing lung screening program data These insights will help you avoid mistakes and get your program right the first time

CT colonography potentially less expensive than optical colonoscopy: study Found to save between 22 and 50 percent in costs

Why settle for less when you can have more with spectral CT? Dr. Amit Gupta describes the benefits that dual-energy spectral CT brings to radiology

Coalition urges CMS clarification on low dose CT guidance

by Thomas Dworetzky , Contributing Reporter
The American College of Radiology (ACR) and other partner groups have sent a formal letter to the U.S. Centers for Medicare and Medicaid Services (CMS) requesting that it confirm that Medicare will reimburse for CT lung cancer screening at Independent Diagnostic Testing Facilities (IDTF).

Its partners include the Radiology Business Management Association (RBMA), the Healthcare Business Management Association (HBMA) the Association for Quality Imaging (AQI), Medical Imaging and Technology Alliance (MITA), and Lung Cancer Alliance (LCA).

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

“We believe that Medicare Administrative Contractors (MACs) are not correctly adhering to the lung cancer screening NCD 210.14. In accordance with the June 12, 2017 Medicare Learning Network Matters article (MM9246), CMS clarified that IDTFs are, in fact, eligible facilities capable of performing low-dose computed tomography (LDCT) lung cancer screening. Nevertheless, MACs regularly exclude LDCT lung cancer screening coverage when performed in the IDTF setting, including at sites that meet the NCD criteria. We hope CMS can clarify these outstanding issues contributing to the MACs’ decision to deny coverage of LDCT lung screening at IDTFs,” the letter stated.

ACR noted in a May 18th statement that physician ignorance of screening guidelines, lack of patient and physician education about screening and “drastically low Medicare reimbursement for low-dose computed tomography (LDCT) lung cancer screening exams” may be resulting in thousands of unnecessary deaths each year.

“CT lung cancer screening can save more lives than any cancer screening test in history, but patients are not hearing about this test from their doctors,” said Dr. Ella Kazerooni, ACR Lung Cancer Screening Committee Chair, in a statement. “Medicare is not adequately covering these exams. This noncompliance and practical non-coverage is contributing to unnecessary deaths due to lack of screening.”

The ACR letter to CMS requested clarification and advised that MACs are misinterpreting the regulations by “erroneously” excluding the screening exams.

“MACs continue to approve payment to IDTFs for 71250 (non-contrast chest CT), while denying LDCT lung cancer screen (G0297), despite being the same type of service (e.g., chest CT). The MACs state that IDTFs are for diagnostic testing, rather than screening.”

The coalition members view this narrow definition of diagnostic exam as erroneous. The MACs, according to the letter, continue to view the screens as “therapeutic intervention.” The coalition letter requested that CMS issue a notice to MACs establishing that they are, in fact, diagnostic, a preventive screening available to Medicare users, that it should be covered wherever it is given, including IDTFs, and that payment should go back to February 5, 2015.
  Pages: 1 - 2 >>

CT Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.